Scott A. Kramer
Research Associate

Contact information
419 Biochemistry Building
Wilson Road
East Lansing, MI 48824
Email: kramersc@pilot.msu.edu

Education
B.S. (1989): Cornell University, Animal Science
M.S. (1991): Michigan State University, Department of Animal Science Growth Biology Program
Ph.D (1998): Michigan State University, Department of Animal Science Muscle and Growth Biology Program

Post-Doctoral Positions
1998-1999: L'Institute Nationale de la Recherche Agronomique Unité de Virologie et Immunologie Moléculaires
Jouy-en- Josas, France

Les équipes:
-Biologie Moleculaire des Rotatvirus
-Interférons et Cytokines


Research Project

The focus of my research within the Molecular and Genomic Toxicology Laboratory at Michigan State University is male endocrine disruption by estrogen-like chemicals using a mouse model system.

Several natural and synthetic chemicals including pharmaceuticals, nutriceuticals,phytoestrogens, pesticides, environmental pollutants and industrial chemicals are known to posses distinct estrogen-like properties and have been examined by our laboratory. My particular investigation will address the effect of the phytoestrogen, genistein, on male reproductive development and fertility in mice.

Genistein is an isoflavone found in unfermented soy products. As a phytosteroid, genistein "imitates" estrogen considering that genistein may compete for estrogen receptors. Genistein may bind to the estrogen receptor without eliciting a large estrogenic response and may therefore inhibit the stronger endogenous estrogenic agonists from binding. Coincidentally, genistein has also been reported to reduce circulating levels of the gonadotrophic hormone, LH, which is crucial in the regulation of steroidogenesis and subsequent spermatogenesis and secondary sex characteristics of males.

The objective is to examine the effect of genistein at distinct reproductive end points in the male mouse at the molecular, cellular and tissue levels. Molecular investigations will feature a testis specific microarray application developed in our laboratory while cellular and tissue level data will include measures of sperm analysis, in vitro fertilization and testis histology respectively.

Furthermore, other potential endocrine disrupting chemicals will be examined for estrogen-like activity including genistein, diethylstilbesterol, and zearalonone. The estrogen-like activity of these chemicals will be assessed taking advantage of the unique estrogen-inducibility of vitellogenin. Vitellogenin is a serum phospholipoglycoprotein precursor to egg yolk in ovoviparous organisms. In vertebrates, estrogen induces vitellogenin in the liver which is then secreted into the bloodstream and taken up by oocytes and is not expressed in the male of the species. Coincidentally, vitellogenin expression has been found to be an excellent biomarker for exposure of males to estrogenic substances. A quantitative competitive reverse transcription-polymerase chain reaction (RT/PCR) will be used for analysis of vitellogenin mRNA standardized to beta-actin.

Curriculum Vitae